Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Marksans Pharma Ltd. Board/Management Information 2018

Aug 25, 2018

62142_rns_2018-08-25_f992ad89-199b-4935-9375-53918fe3d5b4.pdf

Board/Management Information

Open in viewer

Opens in your device viewer

·t· Marksans Pharma Ltd.

BSE Limited Corporate Relation Department Phiroze Jeejeeboi Towers, Dalal Street, Mumbai - 400001. Scrip Code: 524404

National Stock Exchange of India Limited Listing Department Exchange Plaza, C-1, Block-G, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051. Symbol: MARKSANS

This is to inform you that Mis. V. S. Lalpuria & Co., Statutory Auditor of the Company have resigned as Statutory Auditor with effect from the conclusion o.f the forthcoming Annual General Meeting of the Company.

This is further to inform you that the Board of Directors of the Company at its meeting held today i.e. 25[th] August, 2018, has recommended Mis. Bhuta Shah & Co. LLP(FR No. W100100) to the shareholders for appointment as the Statutory Auditor to fill the Casual Vacancy caused by the resignation of Mis. V. S. Lalpuria & Co. The shareholders will consider appointment of Mis. Bhuta Shah & Co. LLP as the Statutory Auditor of the Company at the forthcoming Annual General Meeting.

Yours faithfully For Marksans Pharma Limited

JPawjk Harshavardhan Panigrahl ~ Company Secretary & Manger -legal

www.marksanspharma.com